| Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemia K Lin, PD Sherrington, M Dennis, Z Matrai, JC Cawley, AR Pettitt Blood, The Journal of the American Society of Hematology 100 (4), 1404-1409, 2002 | 319 | 2002 |
| The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes KJ Till, K Lin, M Zuzel, JC Cawley Blood, The Journal of the American Society of Hematology 99 (8), 2977-2984, 2002 | 280 | 2002 |
| TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations T Zenz, D Vollmer, M Trbusek, J Smardova, A Benner, T Soussi, ... Leukemia 24 (12), 2072-2079, 2010 | 213 | 2010 |
| TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients M Pirmohamed, K Lin, D Chadwick, BK Park Neurology 56 (7), 890-896, 2001 | 186 | 2001 |
| Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia AS Kamiguti, L Serrander, K Lin, RJ Harris, JC Cawley, DJ Allsup, ... The Journal of Immunology 175 (12), 8424-8430, 2005 | 156 | 2005 |
| CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia Z Matrai, K Lin, M Dennis, P Sherrington, M Zuzel, AR Pettitt, JC Cawley Blood, The Journal of the American Society of Hematology 97 (6), 1902-1902, 2001 | 124 | 2001 |
| The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia AS Kamiguti, ES Lee, KJ Till, RJ Harris, MA Glenn, K Lin, HJ Chen, ... British journal of haematology 125 (2), 128-140, 2004 | 114 | 2004 |
| B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CβII ST Abrams, T Lakum, K Lin, GM Jones, AT Treweeke, M Farahani, ... Blood 109 (3), 1193-1201, 2007 | 112 | 2007 |
| Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition J Zhuang, SF Hawkins, MA Glenn, K Lin, GG Johnson, A Carter, ... haematologica 95 (1), 110, 2010 | 94 | 2010 |
| Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells K Lin, N Rockliffe, GG Johnson, PD Sherrington, AR Pettitt Oncogene 27 (17), 2445-2455, 2008 | 93 | 2008 |
| LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells F Talab, JC Allen, V Thompson, K Lin, JR Slupsky Molecular Cancer Research 11 (5), 541-554, 2013 | 81 | 2013 |
| B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia DJ Allsup, AS Kamiguti, K Lin, PD Sherrington, Z Matrai, JR Slupsky, ... Cancer research 65 (16), 7328-7337, 2005 | 81 | 2005 |
| High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment K Lin, S Manocha, RJ Harris, Z Matrai, PD Sherrington, AR Pettitt Blood 102 (3), 1145-1146, 2003 | 72 | 2003 |
| Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia A Carter, K Lin, PD Sherrington, AR Pettitt British journal of haematology 127 (4), 425-428, 2004 | 56 | 2004 |
| V (H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia VM Duke, D Gandini, PD Sherrington, K Lin, B Heelan, P Amlot, AB Mehta, ... haematologica 88 (11), 1259-1271, 2003 | 53 | 2003 |
| A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene GG Johnson, PD Sherrington, A Carter, K Lin, T Liloglou, JK Field, ... Cancer research 69 (12), 5210-5217, 2009 | 52 | 2009 |
| c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells JC Allen, F Talab, M Zuzel, K Lin, JR Slupsky Blood, The Journal of the American Society of Hematology 117 (8), 2414-2422, 2011 | 51 | 2011 |
| CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia GG Johnson, K Lin, TF Cox, M Oates, DR Sibson, R Eccles, B Lloyd, ... Blood, The Journal of the American Society of Hematology 122 (26), 4253-4258, 2013 | 50 | 2013 |
| c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications K Lin, MA Glenn, RJ Harris, AD Duckworth, S Dennett, JC Cawley, ... Cancer research 66 (15), 7801-7809, 2006 | 46 | 2006 |
| Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia*[S] GL Eagle, J Zhuang, RE Jenkins, KJ Till, PV Jithesh, K Lin, GG Johnson, ... Molecular & Cellular Proteomics 14 (4), 933-945, 2015 | 44 | 2015 |
